John Morales
- Healthcare Information
- April 4, 2023
- 1 views
Southwest Healthcare Services Announces Data Breach Affecting Patients’ SSNs and PHI | Console and Associates, P.C.
On March 31, 2023, Southwest Health care Companies (“Southwest”) filed a observe of details breach with the Montana Lawyer General right after the group uncovered that an unauthorized bash was…
- Women'S Health
- March 7, 2023
- 0 views
OhioHealth Announces Plan to Build a Destination Center for Women’s Health
OhioHealth announced currently its plan to establish a in depth women’s middle to fulfill the intricate and transforming health care wants of women during the distinct phases of everyday living.…
- Healthcare Information
- February 17, 2023
- 0 views
QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology Specialists of Florida
QHSLab, Inc. WEST PALM Beach front, FL, Feb. 16, 2023 (Globe NEWSWIRE) — QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a organization centered on giving clinicians with tools to leverage proactive,…
- Women'S Health
- January 10, 2023
- 0 views
Aspira Women’s Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary Results in Line with Cash Utilization Guidance, and Other Highlights
Aspira Women’s Wellness Inc. Preliminary tests quantity in the course of the fourth quarter of 2022 was 5,643, an increase of 18 {35112b74ca1a6bc4decb6697edde3f9edcc1b44915f2ccb9995df8df6b4364bc} compared to the fourth quarter of 2021…
- Health And Fitness
- January 3, 2023
- 0 views
Life Time Announces Top Health & Fitness Trends for 2023
Accredited professionals weigh in on mental wellbeing, diet, health, and additional MINNEAPOLIS, Jan. 2, 2023 /PRNewswire/ — Life Time (NYSE: LTH), the nation’s leading nutritious life style brand with more than…
- Medical Treatment
- December 30, 2022
- 0 views
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a affected individual-focused biopharmaceutical company, these days announced that the…
